Mittra R - Search Results

Year	Number of Results
1972	1
1974	1
1975	1
1976	1
1984	1
1992	1
1993	1
1995	1
1996	2
1997	5
1998	5
1999	5
2000	4
2001	1
2002	1
2003	1
2005	2
2006	1
2008	5
2009	6
2010	4
2011	3
2012	4
2013	5
2014	5
2015	5
2016	5
2017	3
2018	2
2019	2
2020	3
2021	7
2022	9
2023	10
2024	3

1

BILATERAL EYE PATCHING MAY IMPROVE CLINICAL OUTCOMES FOR ACUTE PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

Tang PH, Curran CD, Salman AR, Sodhi GS, Vagaggini T, Haq Z, Mittra RA, Dev S, Emerson GG, Parke DW 3rd, Quiram PA, Belin PJ, Sastry A, Ryan EH. Tang PH, et al. Among authors: mittra ra. Retina. 2024 Apr 1;44(4):591-600. doi: 10.1097/IAE.0000000000004004. Retina. 2024. PMID: 37972977 Clinical Trial.

2

IMPACT OF FOVEAL STATUS AND TIMING OF SURGERY ON VISUAL OUTCOME IN RHEGMATOGENOUS RETINAL DETACHMENT.

Haq Z, Mittra RA, Parke DW, Yonekawa Y, Hsu J, Gupta O, Williams GA, Shah GK, Ryan EH. Haq Z, et al. Among authors: mittra ra. Retina. 2024 Jan 1;44(1):88-94. doi: 10.1097/IAE.0000000000003913. Retina. 2024. PMID: 37603408

3

PROPHYLACTIC TREATMENT OF LATTICE DEGENERATION IN FELLOW EYES AFTER REPAIR OF UNCOMPLICATED PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

Curran CD, Adams OE, Vagaggini T, Sodhi GS, Prairie ML, Baker MJ, Sastry A, Ryan EH, Parke DW 3rd, Mittra RA, Dev S, Tang PH. Curran CD, et al. Among authors: mittra ra. Retina. 2024 Jan 1;44(1):63-70. doi: 10.1097/IAE.0000000000003908. Retina. 2024. PMID: 37536462

4

Clinical Factors and Outcomes of Acute-Onset Endophthalmitis Following Small-Gauge Pars Plana Vitrectomy Surgery.

Vagaggini T, Adams OE, Curran CD, Prairie ML, Baker MJ, Sastry A, Ryan EH, Parke DW 3rd, Mittra RA, Tang PH. Vagaggini T, et al. Among authors: mittra ra. Ophthalmic Surg Lasers Imaging Retina. 2023 Jul;54(7):395-400. doi: 10.3928/23258160-20230614-01. Epub 2023 Jun 1. Ophthalmic Surg Lasers Imaging Retina. 2023. PMID: 37418667

5

Advanced Diabetic Retinopathy May Promote Ocular Neovascularization after Central Retinal Artery Occlusion.

Curran CD, Masters TC, Engel KC, Lee MS, Davies JB, Ryan EH, Parke DW 3rd, Mittra RA, Dev S, Tang PH. Curran CD, et al. Among authors: mittra ra. Ophthalmol Retina. 2023 Oct;7(10):932-933. doi: 10.1016/j.oret.2023.06.018. Epub 2023 Jun 29. Ophthalmol Retina. 2023. PMID: 37390939 No abstract available.

6

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.

Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group. Kymes SM, et al. JAMA Ophthalmol. 2023 Jun 1;141(6):554-561. doi: 10.1001/jamaophthalmol.2023.1463. JAMA Ophthalmol. 2023. PMID: 37166820 Free PMC article.

7

Pyrimido[1,2-a]benzimidazoles as inhibitors of oncoproteins ubiquitin specific protease 5 and MYCN in the childhood cancer neuroblastoma.

Gadde S, Kleynhans A, Holien JK, Bhadbhade M, Nguyen PLD, Mittra R, Yu TT, Carter DR, Parker MW, Marshall GM, Cheung BB, Kumar N. Gadde S, et al. Among authors: mittra r. Bioorg Chem. 2023 Jul;136:106462. doi: 10.1016/j.bioorg.2023.106462. Epub 2023 Mar 29. Bioorg Chem. 2023. PMID: 37060785

8

Evaluation of Outcomes of Acute Cataract Surgery-Related Endophthalmitis Using a Novel Management Algorithm Based on Presenting Risk Factors.

Adams OE, Vagaggini T, Groth SL, Curran CD, Prairie ML, Sastry A, Ryan EH, Parke DW, Mittra RA, Dev S, Tang PH. Adams OE, et al. Among authors: mittra ra. Semin Ophthalmol. 2023 Oct;38(7):648-655. doi: 10.1080/08820538.2023.2194985. Epub 2023 Mar 27. Semin Ophthalmol. 2023. PMID: 36971452 Clinical Trial.

9

Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.

Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Regillo C, et al. Among authors: mittra r. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. Ophthalmology. 2023. PMID: 36870451 Free article. Clinical Trial.

10

Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials.

Xue K, Hua P, Maguire MG, Daniel E, Jaffe GJ, Grunwald JE, Ying GS; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Xue K, et al. Ophthalmol Retina. 2023 Jul;7(7):564-572. doi: 10.1016/j.oret.2023.02.008. Epub 2023 Feb 19. Ophthalmol Retina. 2023. PMID: 36803692 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year